JPRN-jRCT2080221820
Unknown
Phase 3
A Long-term Administration Study of Aripiprazole in Children and Adolescents (Age: 6 to 17 Years) With Autistic Disorder
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Autistic Disorder, Children and Adolescents
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) The patient meets Autistic disorder diagnostic criteria defined in DSM\-IV\-TR.
- •2\) The patient has completed the 031\-11\-002 study (the patient has visited the hospital during week8\)
- •3\) Inpatient or outpatient status
- •4\) Othress
Exclusion Criteria
- •1\) The patient is currently diagnosed with another disorder on the autism spectrum in DSMIV\-TR, including Asperger's, Rett's Disorder, PDD\-NOS, Childhood Disintegrative Disorder, or Fragile\-X Syndrome.
- •2\) Patients who fall under a contraindication listed in the ABILIFY package insert
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 3
ong-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients with Major Depressive DisorderMajor Depressive DisorderJPRN-jRCT2080220699Otsuka Pharmaceutical Co., Ltd.100
Unknown
Phase 3
A short treatment study of aripiprazole in pediatric patients with Autistic DisorderAutistic Disorder, children and adolescentsJPRN-jRCT2080221819Otsuka Pharmaceutical Co., Ltd.
Active, not recruiting
Phase 1
Safety and Efficacy of Aripiprazole in the Long-Term MaintenanceTreatment ofPediatric Subjects with Irritability Associated with Autistic DisorderIrritability in Autism DisorderTherapeutic area: Psychiatry and Psychology [F] - Behaviours [F01]EUCTR2017-000174-11-Outside-EU/EEAOtsuka Pharmaceutical Development & Commercialization, Inc215
Completed
Phase 3
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic DisorderAutistic DisorderNCT01617460Otsuka Pharmaceutical Co., Ltd.86
Completed
Not Applicable
Observational study of the effect of aripiprazole on waking difficultyPatient being treated for depression with difficulty waking up for which aripiprazole was prescribedJPRN-UMIN000048309Kurume University School of Medicine12